Lipella Pharmaceuticals Inc (LIPO) Directors and Executive Officers

Officers & Directors

Jonathan Kaufman
Director

Douglas Johnston
Director

Lori Birder
Director

Ryan Pruchnic
Director

Michael Chancellor
Director

Byong (Christopher) Kim
Director

Daniel Cohen
Director

Naoki Yoshimura
Director ,

Lipella Pharmaceuticals Inc currently has 16 employees.

News about Lipella Pharmaceuticals Inc Key Personnel

Lipella Pharmaceuticals: A Promising Drug Pursuit Shrouded in Financial Uncertainty,

Lipella Pharmaceuticals Faces Financial Challenges Amid Promising Drug DevelopmentIn a recent appearance on the Pharmaverse podcast, Michael Chancellor, co-founder of Lipella Pharmaceuticals, discussed the company’s innovative pursuit of new therapeutic solutions, notably the LP-310, aimed at treating oral lichen planus (OLP). However, while the enthusiasm surrounding Lipella s latest drug candidate is palpable, the company s financial situation presents a stark contrast, sparking scrutiny from investors and industry analysts alike.Fiscal reports reveal that Lipella Pharmaceuticals recorded a cumulative net loss of $4 million during the 12 months ending in the third quarter of 2024. This significant defi...

Lipella Pharmaceuticals Secures FDA Clearance for LP-410, Potentially Revolutionizing Oral Graft-Versus-Host Disease Treatment

In a recent press release, Lipella Pharmaceuticals announced the Food and Drug Administration (FDA) clearance of Investigational New Drug (IND) for LP-410, a potential breakthrough treatment for oral Graft-Versus-Host Disease (GVHD). This exciting development signifies another step forward in Lipella s clinical pipeline, offering hope for patients suffering from this complex condition.
GVHD is a common and potentially life-threatening complication that can occur after a stem cell or bone marrow transplant. The condition arises when the newly transplanted immune cells recognize the recipient s body as foreign and attack healthy tissues, particularly affecting the mouth and throat. Oral GVHD can cause...